Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients

NCT00941369 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine (HOE901)/NPH Insulin

Sponsor

Sanofi